Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Wai-Tim Jim is active.

Publication


Featured researches published by Wai-Tim Jim.


Pediatric Infectious Disease Journal | 2004

Transmission of cytomegalovirus from mothers to preterm infants by breast milk.

Wai-Tim Jim; Chyong-Hsin Shu; Nan-Chang Chiu; Hsin-An Kao; Han-Yang Hung; Jui-Hsing Chang; Chun-Chih Peng; Wen-Shyang Hsieh; Kuei-Chen Liu; Fu-Yuan Huang

Objectives: To assess the risk of transmission of cytomegalovirus (CMV) by breast milk from CMV-seropositive mothers to their breast-fed preterm infants and to evaluate their outcome. Patients and Methods: The study population comprised breast-fed preterm infants with a birth weight of <1500 g and gestational age of <35 weeks. Venous blood samples from the mothers and infants were tested for CMV IgG and IgM antibodies on the 5th and 30th day after birth. Breast milk was obtained for CMV DNA detection by polymerase chain reaction and viral culture on the 5th day and on the 3rd, 6th and 12th week. Urine samples of the babies were collected at the same time for CMV culture. Neurodevelopmental assessment was done at 6 months of age, corrected for preterm birth. Results: Thirty-eight mothers and 42 infants (including 4 sets of twins) were enrolled in the study. A mother-infant pair was excluded because of inadequate breast milk collection. Thirty-six mothers (97.3%) were CMV-seropositive. CMV DNA of breast milk was detected in 35 seropositive mothers. Six infants of 5 mothers were infected (infected group) at a mean of 77 days after birth, and 34 infants of 31 mothers were not (noninfected group). In all the mothers of the infected group, CMV virus could be cultured from the milk whey. The average maternal CMV IgG on day 5 after delivery was higher in the infected than in the noninfected group. Sepsis-like symptoms and hyperbilirubinemia were more frequently noted in the infected infants than in the noninfected, but the difference was not statistically significant. Neurodevelopmental outcome did not significantly differ between the 2 groups. Conclusions: The risk of CMV infection in breast-fed premature infants was highest when the mothers shed viable virus in their breast milk. These mothers had high CMV IgG, which may help identify those mother-infant pairs at risk. Inactivation of the virus in milk by freezing may be a way of reducing the transmission of this virus via breast milk.


Pediatric Infectious Disease Journal | 2009

High cytomegalovirus load and prolonged virus excretion in breast milk increase risk for viral acquisition by very low birth weight infants.

Wai-Tim Jim; Chyong-Hsin Shu; Nan-Chang Chiu; Jui-Hsing Chang; Han-Yang Hung; Chun-Chih Peng; Hsin-An Kao; Tsai-Yin Wei; Chia-Lien Chiang; Fu-Yuan Huang

Background: Breast milk is the main source of postnatal human cytomegalovirus (HCMV) infection. The aim of this study was to assess the relationship between HCMV load in breast milk and viral transmission to very low birth weight (VLBW) infants. Methods: Breast-fed VLBW infants who were born to HCMV-seropositive mothers and who were managed in a neonatal intensive care unit were enrolled in the study. Blood from mothers and infants was tested for HCMV antibodies after birth. Breast milk was collected for viral culture and HCMV load measurement. Urine from the babies was obtained for HCMV-DNA detection. Symptoms of HCMV infection were recorded and evaluated by neonatologists. Results: Of the 23 evaluated mothers during a 1-year period, 19 were HCMV seropositive; 17 of the women had detectable HCMV-DNA in their breast milk whey. Of the 23 infants born to the 19 seropositive mothers, 8 infants of 8 mothers had HCMV-DNA detected in the urine, indicating that they were infected, even though the breast milk was always frozen prior to feeding. Three infected infants had symptoms. At 4 weeks after delivery, the median viral load in breast milk from mothers of the 8 infected infants was significantly higher than that from mothers of the 15 noninfected infants (P = 0.04). HCMV was detectable in breast milk for a significantly longer period in mothers of infected infants (7.5 vs. 2.6 weeks P = 0.03). Conclusions: High HCMV load and prolonged virus excretion in breast milk are maternal risk factors for viral transmission to VLBW infants.


Pediatrics and Neonatology | 2011

The Changing Face of Early-onset Neonatal Sepsis After the Implementation of a Maternal Group B Streptococcus Screening and Intrapartum Prophylaxis Policy—A Study in One Medical Center

Chia-Ying Lin; Chyong-Hsin Hsu; Fu-Yuan Huang; Jui-Hsing Chang; Han-Yang Hung; Hsin-An Kao; Chun-Chih Peng; Wai-Tim Jim; Hsin Chi; Nan-Chang Chiu; Tung-Yao Chang; Chen-Yu Chen; Chie-Pein Chen

BACKGROUND Early-onset sepsis (EOS) is the major cause of neonatal morbidity and mortality. Maternal group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis (IAP) were implemented in our hospital in 2004. Our aim was to evaluate the effectiveness of the program and changes in pathogens and antibiotic susceptibility. METHODS The medical charts of mothers and infants with EOS between January 2001 and November 2008 were retrospectively reviewed. EOS was defined as sepsis occurring within 72 hours of birth. Data were pooled and compared for January 2001 through September 2004 (Period 1, without GBS screening) and October 2004 through November 2008 (Period 2, with GBS screening and IAP). RESULTS The GBS screening rate increased from 10.11% in 2004 to 65% in 2008 and the IAP rate increased from 40% in 2004 to 90% in 2008. The most common EOS pathogen in Period 1 was GBS (45.4%), which decreased to 20% in Period 2 (p=0.081; trend p=0.009). The percentage of EOS because of Escherichia coli in Period 1 was 40.9% but increased to 70% in Period 2 (p=0.059). E coli EOS increased in extremely low birth weight premature babies weighing 500-1000g from Period 1 to Period 2 (p=0.031). The incidence of ampicillin-resistant E coli EOS was relatively high, but no significant change (88.9% vs. 92.9%) after implementation of GBS screening and IAP was noted. CONCLUSION GBS screening plus IAP is effective in decreasing the incidence of GBS EOS; however, an increase in EOS caused by E coli was noted. Monitoring of pathogens causing EOS is important for effective treatment.


Pediatrics and Neonatology | 2009

Clinical Manifestations, Laboratory Findings and Complications of Pediatric Scrub Typhus in Eastern Taiwan

Wai-Tim Jim; Nan-Chang Chiu; Wai-Tao Chan; Che-Sheng Ho; Jui-Hsing Chang; Shi-Yu Huang; Sun Wu

BACKGROUND Scrub typhus is a clinically important endemic disease in Taiwan. The aims of this study were to analyze the clinical manifestations, laboratory data and complications of pediatric scrub typhus in eastern Taiwan. PATIENTS AND METHODS We searched medical records for all patients with scrub typhus who were hospitalized between 1992 and 2002 at the Taitung branch of Mackay Memorial Hospital, Taiwan. Records of children under the age of 18 with a confirmed diagnosis were selected for retrospective review. RESULTS During the study period, 145 patients fulfilled the diagnostic criteria for scrub typhus, of whom 106 (73%) were adults and 39 (27%) were children. The mean age of the children was 7.6+/-4.6 years. The most common clinical manifestations of pediatric scrub typhus were fever (n=39; 100%), cough (n=28; 72%), anorexia (72%), eschar (69%), chill (67%) and lymphadenopathy (64%). The most common complications were hepatic dysfunction (77%) and pneumonitis (54%). Three children (8%) required intensive care, but the overall survival rate was 97%. One child died with multi-organ failure within 8 hours after admission. CONCLUSION Scrub typhus should be considered in children with fever and hepatic dysfunction, particularly in those with a history of environmental exposure in an endemic area for scrub typhus. The presence of an eschar offers an important diagnostic clue, but not for all cases. Children with scrub typhus may develop serious complications and may even die if appropriate treatment is not given. Doxycycline is an effective antibiotic for pediatric scrub typhus in Taiwan.


Journal of The Formosan Medical Association | 2003

Treatment of severe meconium aspiration syndrome with dilute surfactant lavage

Hung-Yang Chang; Chyong-Hsin Hsu; Hsin-An Kao; Han-Yang Hung; Jui-Hsing Chang; Chun-Chih Peng; Wai-Tim Jim

BACKGROUND AND PURPOSE Despite the development of new adjuvant therapies, meconium aspiration syndrome (MAS) remains a serious respiratory disorder in neonates. Surfactant inactivation by meconium can be overcome by use of exogenous surfactant. This study sought to assess the efficacy and safety of dilute surfactant lavage at 2 different concentrations to treat severe MAS. METHODS We retrospectively reviewed the charts of all term infants with a diagnosis of MAS who had an oxygenation index (OI) > 20 during a 2-year period. Tracheobronchial lavage was performed with a dilute surfactant suspension (5 mg/mL or 10 mg/mL) to reach a total dose of 60 to 70 mg/kg of phospholipid, administered in aliquots of 2 mL. RESULTS The records of 22 patients were reviewed, of whom 12 had undergone lavage. These patients were subdivided into low-concentration (surfactant concentration, 5 mg/mL; n = 6) and high-concentration (surfactant concentration, 10 mg/mL; n = 6) subgroups. There were no significant differences in demographic characteristics between these 2 subgroups. The lavaged infants had a significantly higher arterial partial pressure of oxygen (PaO(2)) 24 hours after lavage than the infants without lavage (178.3 mm Hg vs 80.6 mm Hg, p < 0.05). The incidence of pneumothorax (1/12 vs 7/10, p < 0.05) and requirement for inhaled nitric oxide (5/12 vs 9/10, p < 0.05) were significantly lower in the lavaged group. All infants tolerated the procedure well except for 2 with transient complications. There were no significant differences in duration of lavage, response and complications between subgroups lavaged at low and high surfactant concentration. CONCLUSIONS Early lavage with dilute surfactant solution at a phospholipid concentration of either 5 mg/mL or 10 mg/mL is effective for the treatment of severe MAS. Further large-scale, prospective, randomized, controlled trials are necessary to establish the optimal dose, concentration, surfactant product, and instillation method of this treatment before it can be recommended for routine use.


Medicine | 2015

Outcome of preterm infants with postnatal cytomegalovirus infection via breast milk: A two-year prospective follow-up study

Wai-Tim Jim; Nan-Chang Chiu; Che-Sheng Ho; Chyong-Hsin Shu; Jui-Hsing Chang; Han-Yang Hung; Hsin-An Kao; Hung-Yang Chang; Chun-Chih Peng; Bey-Hwa Yui; Chih-Pin Chuu

AbstractApproximately 15% of preterm infants may develop postnatal cytomegalovirus (CMV) infection from seropositive mothers via breast milk and are at risk for neurological sequelae in childhood. The aims of this study were to assess the effects and outcomes on growth, neurodevelopmental status, and hearing in very low birth weight (VLBW) premature infants with postnatal CMV infection via breast milk at the corrected age of 12 and 24 months.The prospective follow-up study population comprised all living preterm children (n = 55) with a birth weight ⩽1500 g and gestational age of ⩽35 weeks, who had been participated in our “postnatal CMV infection via breast milk” studies in 2000 and 2009, respectively. The cohort of children was assessed at 12 and 24 months. Clinical outcomes were documented during hospitalization and after discharge. Long-term outcomes included anthropometry, audiologic tests, gross motor quotient, Infant International Battery, and neurodevelopmental outcomes; all were assessed at postcorrected age in 12 and 24 months during follow-up visits.Of the 55 infants enrolled in the study (4 noninfected infants were excluded because their parents did not join this follow-up program later), 14 infants postnatally acquired CMV infection through breast-feeding (infected group) and were compared with 41 infants without CMV infection (control group). No significant differences were observed between the groups with regard to baseline characteristics, clinical outcomes, anthropometry, or psychomotor and mental development on the Bayley scale of infant development. None of the infants had CMV-related death or permanent sensorineural hearing loss.Transmission of CMV from seropositive mother via breast milk to preterm infants does not appear at this time to have major adverse effects on clinical outcomes, growth, neurodevelopmental status, and hearing function at 12 and 24 months corrected age.


Acta paediatrica Taiwanica | 2006

Small Versus Large Volume Dilute Surfactant Lavage for Meconium Aspiration Syndrome

Han-Yang Hung; Wai-Tim Jim; Chyong-Hsin Hsu; Jui-Hsing Chang; Chun-Chi Peng; Shin-Lin Shih; Hung-Yang Chang; Hsin-An Kao

BACKGROUND Surfactant lavage has been used to treat neonatal meconium aspiration syndrome (MAS). OBJECTIVE To assess the effects of lavage with a small volume of dilute surfactant in neonates with MAS, and compare the results with those of historical controls treated with larger volumes. METHODS From August 2002 to June 2005, we treated 11 newborns with MAS using 20 ml of dilute surfactant at a phospholipid concentration of 10 mg/ml (SVL group). We compared the results with those of 9 infants previously treated with large-volume lavage (LVL group), using 40 ml of dilute surfactant, 5 mg/ml. RESULTS Both groups were similar at baseline except for a higher mean birth weight in the LVL group (3.29+/-0.36 vs 2.92+/-0.4 kg, P = 0.04). The lavage procedure was longer in the LVL than the SVL group (48.89 +/-7.41 vs. 30.91+/-5.83 mins, P <0.001). Measures of oxygenation, including mean PaO2, oxygenation index, and arterial/alveolar 02 ratio, showed no significant difference between the two groups. Adverse events in the LVL group included transient hypoxemia in 3 infants and white- out on chest x-ray in 5 cases. None of the patients in the SVL group had these findings. The peak mean airway pressure in.the LVL group was higher than that in the SVL group (16.0+/-2. 65 vs 13.3+/-3.01 cmH2O, P = 0.046). CONCLUSIONS SVL has the same benefits in neonatal MAS as LVL. However, SVL appears to be associated with fewer adverse events.


Clinical Neonatology | 2007

Meconium Obstruction in Very Low Birth Weight Premature Infants

Yun-Yun Yu; Han-Yang Hung; Hsin-An Kao; Chyong-Hsin Shu; Jui-Hsing Chang; Wai-Tim Jim; Fu-Yuan Huang

Objective: The aim of this study was to identify the clinical signs and symptoms, clinical diagnosis and management of meconium obstruction in preterm and very low birth weight (VLBW) infants. We also wanted to identify the risk factors associated with meconium obstruction in prematurity. Methods: The medical records of premature infants with a diagnosis of meconium obstruction during a 5-year period were admitted to the neonatal intensive care unit (NICU) at the Mackay Memorial Hospital, Taipei, Taiwan were investigated. Infants with the diagnosis of gastroschisis, intestinal atresia, Hirschsprung’s disease, microcolon, malrotation, motility disorder, volvulus, sepsis, hypothyroidism and congenital anomalies were excluded. Results: Twelve infants were included in our study. Maternal hypertension was seen in five cases and four received MgSO4. The average time of first stool passage was 2.75 days. Abdominal distension developed between the ages of 3 to 14 days with a mean of 6.58 days of life. Forty-two percent of the symptomatic infants experienced resolution of obstruction using warm isotonic sodium chloride solution or diluted Gastrograffin enema alone. Four infants complicated with intestinal perforation. Conclusion: The risk factors include maternal history of hypertension with or without magnesium sulfate therapy. These premature infants with meconium obstruction are not clinically sick. Isotonic sodium chloride solution enemas are safe and effective intervention. Delayed diagnosis was associated with perforation and postponement in attaining adequate enteral feeding.


Clinical Neonatology | 2006

The Effect of Planned Maternal Transport on Postnatal Outcomes in Very Low Birth Weight Infants

Ming-Jen Chen; Chyong-Hsin Shu; Hsin-An Kao; Han-Yang Hung; Jui-Hsing Chang; Wai-Tim Jim; Fu-Yuan Huang

Objectives: The purpose of this study was to evaluate the effect of planned maternal transport on the outcomes of very-low-birth-weight (VLBW) infants in Taiwan. Patients and Methods: From January 1995 to October 2002, a retrospective data review was performed of all VLBW infants with antenatal maternal transport in twenty medical centers which joined the national multi-center collaborative follow-up program of the Taiwan Premature Infant Developmental Collaborative Study Group. A total of 1390 VLBW infants from 20 hospitals met the enrollment criteria and were divided into 2 groups: the planned maternal transport group (n=655) and the unplanned maternal transport group (n=735). Data were collected including maternal information, delivery modes and condition at birth, and neonatal morbidity and mortality. Results: Infants born after planned and unplanned maternal transport had similar gestational ages, 1 and 5 minute Apgar scores, need for resuscitation at birth, and the other characteristics. There was no significant difference in neonatal mortality between the two groups. The mean birth weight, incidence of hypotension within 24 hours of NICU admission, apnea, respiratory distress syndrome and the overall incidence of intraventricular hemorrhage were statistically lower in planned maternal transport group. The numbers of babies whose mothers received antenatal steroid treatment and Cesarean delivery were significantly higher in the planned maternal transport group. The use of antenatal steroids was an important factor in reducing intraventricular hemorrhage in VLBW infants. Conclusions: Our study indicates that planned maternal transport decreases the incidence of intraventricular hemorrhage and improves the short-term outcomes in very low birth weight infants. These results might be due to the adequate prenatal care such as the antenatal steroid treatment and evaluation of the indications for Cesarean section.


Journal of The Formosan Medical Association | 2018

Outcomes and related factors in a cohort of infants born in Taiwan over a period of five years (2007–2011) with borderline viability

Jui-Hsing Chang; Chyong-Hsin Hsu; Kuo-Inn Tsou; Wai-Tim Jim

BACKGROUND Advances in perinatal and neonatal care have increased the survival of extremely preterm infants, but the viability limit is still debated. Here we assess the survival, neonatal morbidity, and neurodevelopmental outcomes at 2 years of age of infants born at 22-26 weeks of gestation in Taiwan between 2007 and 2011. METHODS This is a prospective longitudinal multicenter cohort study on extremely preterm infants registered in the Taiwan Premature Infant Developmental Collaborative Study Group from 2007 to 2011, including 22 neonatal care centers. We extracted demographic and clinical data of infants born at 22-26 weeks, and obtained growth and developmental outcome data from the follow-up clinic at 24 months of corrected age. Multivariate analyses using a logistic regression model identified factors significantly impacting survival. RESULTS 647 of the 1098 infants included in the study (58.9%) survived to discharge. Survival rates were 8% (4/50), 25% (27/108), 46.8% (117/250), 67.0% (211/315), and 76.8% (288/375) for infants born at 22, 23, 24, 25, and 26 weeks, respectively. Most survivors (567/647, 87.6%) had major morbidities during hospitalization, and we identified factors that positively and negatively affected survival. 514 (79.4%) patients received follow-up evaluation at 2 years, and 204 (39.7%) of them had neurodevelopmental impairment (NDI) with an incidence of 75%, 65.2%, 49.5%, 39.5%, and 32.8% for infants born at 22, 23, 24, 25, and 26 weeks, respectively. CONCLUSION Infants born at 22 and 23 weeks have a very low likelihood of surviving with little or no impairment. These findings are valuable for parental counseling and perinatal care decisions.

Collaboration


Dive into the Wai-Tim Jim's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Han-Yang Hung

Kaohsiung Medical University Chung-Ho Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Hsin-An Kao

Taipei Medical University

View shared research outputs
Top Co-Authors

Avatar

Chun-Chih Peng

Mackay Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fu-Yuan Huang

Mackay Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bey-Hwa Yui

Mackay Memorial Hospital

View shared research outputs
Top Co-Authors

Avatar

Che-Sheng Ho

Mackay Memorial Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge